A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel

The purpose of the real-time pressure controller proposed in this experiment is to overcome the deficiencies of the existing technology and provide a pressure filling device for the prevention of chemotherapy-induced peripheral neuropathy that can accurately control the pressure, with the pressure decreasing in a sequential manner from the distal end (toes/fingers) to the proximal end (wrists, limbs). The application of this device is of great clinical significance to reduce the peripheral neurotoxicity of paclitaxel and to improve patients' drug compliance. The application of cold compresses

Trial Details

NCT ID

NCT07019233

Phase

NA

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Status

RECRUITING

Cancer Type

Breast Cancer

Interventions

• Real Time Pressure Controller

Locations (sample)

• Tianjin, China|39.14222,117.17667

Key Eligibility Criteria

• Voluntarily signed written informed consent;
• Age ≥18 years and ≤75 years at enrollment, male or female patients;
• Eastern Cooperative Oncology Group (ECOG) physical status score of 0 or 1;
• Suitable for albumin-paclitaxel antitumor therapy;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →